Paracetamol-Diclofenac Versus Pentazocine-Diclofenac for Post-Caesarean Section Pain Relief: A Double Blind...

Effective pain relief after caesarean section (CS) is desirable but pentazocine which has been a common component of multimodal analgesia may delay early mobilization and mother-child interaction due to its side effects.

This study compared the efficacy of paracetamol-diclofenac with pentazocine-diclofenac for post- CS analgesia.

A double-blind randomized controlled trial of three hundred and eighteen consenting parturients who had elective or emergency caesarean section were randomly assigned to two groups. A total of 159 participants were assigned to each group: one group received 750 mg of intravenous paracetamol, while the other received 30 mg of intravenous pentazocine. Both also had 100 mg of rectal suppository diclofenac as multimodal post-caesarean section analgesia in the first 24 hours after surgery. Post-operative pain was assessed by a visual analogue scale six hourly post-operatively. Data obtained was analysed using SPSS 26 and statistical significance was at p < 0.05. The study is registered with the Pan African Clinical Trials Registry with trial number PACTR202501703002153.

The median pain scores in both groups ranged from 2.5 to 4 across all periods of assessment. However, at the first assessment conducted at six hours post-operatively, the scores were higher-4.5 in the pentazocine-diclofenac arm and 5 in the paracetamol-diclofenac arm. Pain relief was slightly better in the pentazocine-diclofenac group, but this was not statistically significant. The pentazocine-diclofenac group experienced significantly more side effects, specifically nausea and drowsiness, compared to the paracetamol-diclofenac group (P < 0.001). Patient satisfaction with pain relief was not significantly different between both groups (p=0.101).

Pentazocine-Diclofenac provided better analgesia than Paracetamol-Diclofenac in the first 24 hours after caesarean section but was associated with more side effects.